Duo Fight For Fingolimod Share In Canada
Patent-Infringement Actions Were Discontinued
Teva and Pharmascience are going head-to-head in a battle to capture the market for generic Gilenya fingolimod capsules in Canada.

Teva and Pharmascience are going head-to-head in a battle to capture the market for generic Gilenya fingolimod capsules in Canada.